title: Functional expression, purification and high sequence coverage mass spectrometric characterization of human excitatory amino acid transporter EAAT2.
abstract: The glial excitatory amino acid transporter 2 (EAAT2) mediates a majority of glutamate re-uptake in human CNS and, consequently, is associated with a variety of signaling and pathological processes. While our understanding of the function, mechanism and structure of this integral membrane protein is increasing, little if any mass spectrometric (MS) data is available for any of the EAATs specifically, and for only a few mammalian plasma membrane transporters in general. A protocol to express and purify functional EAAT2 in sufficient quantities to carry out MS-based peptide mapping as needed to study ligand-transporter interactions is described. A 6xHIS epitope was incorporated into the N-terminus of human EAAT2. The recombinant protein was expressed in high levels in mammalian HEK 293T cells, where it exhibited the pharmacological properties of the native transporter. EAAT2 was purified from isolated cell membranes in a single step using nickel affinity chromatography. In-gel and in-solution trypsin digestions were conducted on the isolated protein and then analyzed by MALDI-TOF and LC-MS/MS mass spectrometry. Overall, 89% sequence coverage of the protein was achieved with these methods. In particular, an 88 amino acid tryptic peptide covering the presumed substrate binding domains HP1, TMD7, HP2, and TMD8 domains of EAAT2 was also identified after N-deglycosylation. Beyond the specific applicability to EAAT2, this study provides an efficient, simple and scalable approach to express, purify, digest and characterize integral membrane transporter proteins by mass spectrometry.
authors.affiliation: Center for Structural and Functional Neuroscience, Department of Chemistry and Biochemistry, The University of Montana, Missoula, MT 59812, USA.
authors.forename: Ran
authors.initials: R
authors.lastname: Ye
authors.forename: Joseph F
authors.initials: JF
authors.lastname: Rhoderick
authors.forename: Charles M
authors.initials: CM
authors.lastname: Thompson
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Bridges
mesh_terms: D000595:Amino Acid Sequence; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism; D004591:Electrophoresis, Polyacrylamide Gel; D027342:Excitatory Amino Acid Transporter 2 / Q000737:chemistry* / Q000235:genetics* / Q000302:isolation & purification / Q000378:metabolism; D015870:Gene Expression; D006801:Humans; D008969:Molecular Sequence Data; D012995:Solubility; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D014357:Trypsin / Q000378:metabolism
chemical_list: D027342:Excitatory Amino Acid Transporter 2; D014357:Trypsin
references.citation: Protein Expr Purif. 2007 Nov;56(1):62-71
references.pmid: 17646109
references.citation: J Proteome Res. 2002 Jul-Aug;1(4):351-60
references.pmid: 12645891
references.citation: Neurochem Int. 2004 Oct;45(5):583-95
references.pmid: 15234100
references.citation: Nat Biotechnol. 2001 Mar;19(3):242-7
references.pmid: 11231557
references.citation: J Biol Chem. 2002 Jul 19;277(29):26074-80
references.pmid: 11994293
references.citation: J Proteome Res. 2004 Jul-Aug;3(4):807-12
references.pmid: 15359735
references.citation: Prog Neurobiol. 2001 Sep;65(1):1-105
references.pmid: 11369436
references.citation: Pharmacol Ther. 2005 Sep;107(3):271-85
references.pmid: 16112332
references.citation: Neuropharmacology. 2005 Nov;49(6):850-61
references.pmid: 16183084
references.citation: Pflugers Arch. 2004 Feb;447(5):465-8
references.pmid: 14624363
references.citation: Trends Mol Med. 2005 Dec;11(12):555-62
references.pmid: 16278094
references.citation: Neuron. 2000 Mar;25(3):695-706
references.pmid: 10774736
references.citation: J Mol Biol. 2005 Aug 19;351(3):598-613
references.pmid: 16024041
references.citation: Protein Expr Purif. 2001 Jul;22(2):337-48
references.pmid: 11437611
references.citation: Curr Opin Cell Biol. 2004 Dec;16(6):653-62
references.pmid: 15530777
references.citation: Curr Opin Pharmacol. 2003 Feb;3(1):101-9
references.pmid: 12550750
references.citation: Neuroscience. 1992 Nov;51(2):295-310
references.pmid: 1465194
references.citation: Neuron. 1998 Dec;21(6):1487-98
references.pmid: 9883740
references.citation: Nature. 2009 Dec 17;462(7275):880-5
references.pmid: 19924125
references.citation: Trends Biochem Sci. 2001 Sep;26(9):534-9
references.pmid: 11551789
references.citation: Nature. 2007 Jan 25;445(7126):387-93
references.pmid: 17230192
references.citation: Ann Neurol. 1995 Jul;38(1):73-84
references.pmid: 7611729
references.citation: PLoS One. 2008 Jun 04;3(6):e2314
references.pmid: 18523555
references.citation: Nature. 1996 Oct 17;383(6601):634-7
references.pmid: 8857541
references.citation: J Biol Chem. 1996 Nov 1;271(44):27715-22
references.pmid: 8910364
references.citation: Nature. 2004 Oct 14;431(7010):811-8
references.pmid: 15483603
references.citation: Curr Top Med Chem. 2006;6(10):961-8
references.pmid: 16787270
references.citation: Biochemistry. 1990 Jul 17;29(28):6734-40
references.pmid: 1697765
references.citation: Curr Opin Pharmacol. 2006 Feb;6(1):7-17
references.pmid: 16377242
references.citation: Curr Top Med Chem. 2006;6(8):823-47
references.pmid: 16719820
references.citation: J Proteome Res. 2008 Feb;7(2):570-8
references.pmid: 18179165
references.citation: Gene Ther. 2000 Aug;7(15):1304-11
references.pmid: 10918501
references.citation: J Proteome Res. 2007 Jun;6(6):2068-79
references.pmid: 17472360
references.citation: J Neurosci. 1995 Mar;15(3 Pt 1):1835-53
references.pmid: 7891138
references.citation: J Neuropathol Exp Neurol. 1997 Aug;56(8):901-11
references.pmid: 9258260
references.citation: Hum Gene Ther. 1999 Sep 20;10(14):2295-305
references.pmid: 10515449
references.citation: Biochem Pharmacol. 2004 Oct 15;68(8):1507-14
references.pmid: 15451393
references.citation: Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2589-94
references.pmid: 19202063
references.citation: Trends Pharmacol Sci. 1998 Aug;19(8):328-34
references.pmid: 9745361
references.citation: Methods Enzymol. 1994;230:44-57
references.pmid: 8139511
references.citation: Neuron. 1998 Sep;21(3):623-32
references.pmid: 9768848
references.citation: Biochemistry. 2001 Jun 5;40(22):6628-35
references.pmid: 11380257
references.citation: Eur J Biochem. 1995 Nov 1;233(3):947-53
references.pmid: 8521863